Guess which ASX 200 tech stock is rising on $30m contract win

Another contract win has been announced by this high-flying stock. Let's dig deeper into it.

| More on:
Researchers and doctors with futuristic 3d hologram overlay for body anatomy or dna in hospital clinic.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Pro Medicus Limited (ASX: PME) shares are rising on Monday morning.

At the time of writing, the ASX 200 tech stock is up 1% to $258.00.

This has been driven by the release of another positive announcement.

ASX 200 tech stock rises on contract win

This morning, the leading health imaging company announced its fourth major contract win in just over a month.

As readers may be aware, at the end of November, the ASX 200 tech stock announced a $24 million deal with NYU Langone Health and a massive $330 million deal with Trinity Health. It then followed this up with the signing of a $30 million deal with Duly Health and Care last week.

Today the company has announced another win. And while it is the smallest of the four, it is with an existing client and is a transaction-based model with potential upside.

According to the release, the ASX 200 tech stock has signed an additional $15 million, five-year contract with Duke University Health System. It is a leading North American academic medical centre.

The release notes that the contract, which is based on a transaction-based licensing model, will see the Visage 7 Open Archive supplement the existing Visage 7 Viewer contract signed with Duke University Health System in May 2019.

What is Visage 7 Open Archive?

Visage 7 Open Archive is a native, optional module of Visage 7. The company notes that it is designed for optimal interoperability, excelling in modular, multi-system, multi-vendor environments by enabling efficient workflows, integration, and consolidation of disparate systems.

As part of the deal, Duke's current on-premise instance of Visage will be deployed to the cloud along with Visage 7 Open archive. The Visage 7 Viewer contract has been extended for a further two years to the end of 2029, as part of the deal.

Pro Medicus advised that planning for the rollout is to commence immediately and will involve the migration of Duke University Health System's current archive to the Visage 7 Open Archive.

The ASX 200 tech stock's CEO, Dr Sam Hupert, was pleased with the deal and believes it is another positive sign for the future. He said:

This deal that confirms our belief that there is a material opportunity for us to sell Visage 7 Open Archive to our existing base of "viewer only" clients. Not only does this provide clients with a highly performant, highly scalable solution, it is a key step in facilitating their transition from on-premise to cloud, a trend we see continuing.

Motley Fool contributor James Mickleboro has positions in Pro Medicus. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has recommended Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

The last piece of the jigsaw being fitted, indicating good news for a share price on merger or acquisition
Healthcare Shares

What will happen to the Sigma share price after the Chemist Warehouse merger?

Morgan Stanley analysts explain the default factor that will support the Sigma share price after the merger.

Read more »

A happy girl in a yellow playsuit with a zip gives the thumbs up
Share Gainers

Why is the Zip share price rocketing 7% today?

Exciting news from the US could be the catalyst for investor buying now.

Read more »

A man wearing a shirt, tie and hard hat sits in an office and marks dates in his diary.
Materials Shares

BHP share price higher on US$2b acquisition to support artificial intelligence market

BHP is ready to step up and help support the booming AI megatrend.

Read more »

Shot of a young scientist looking stressed while conducting medical research in a laboratory.
Broker Notes

Why this top fundie has a 'loss of confidence' in CSL shares

CSL has a lot of broker support right now but Firetrail has an opposing view on the ASX 200 healthcare…

Read more »

Four happy team members working together in a warehouse.
Share Market News

Why is the ASX 200 having such a stellar run today?

The ASX 200 is on fire today. But why?

Read more »

Two happy excited friends in euphoria mood after winning in a bet with a smartphone in hand.
Share Gainers

Why Arafura, Genesis Minerals, Life360, and Premier Investments shares are shooting higher

These shares are climbing more than most on Thursday. But why?

Read more »

Frustrated stock trader screaming while looking at mobile phone, symbolising a falling share price.
Share Fallers

Why Computershare, Ora Banda, Origin Energy, and Vulcan shares are falling today

These shares are missing out on the good times on Thursday. But why?

Read more »

Shot of a young scientist using a digital tablet while working in a lab.
Share Market News

Up 160% in a year, why this ASX 200 healthcare stock is surging again today

Pro Medicus Limited (ASX: PME) shares are having a good start to the session. In morning trade, the ASX 200…

Read more »